![](/sites/all/themes/de_puggle/images/toh-logo.jpg) |
Neonatal Drug Therapy Manual |
Pneumococcal Conjugate Vaccine
Disclaimer: Official controlled document is the CHEO and Ottawa Hospital online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.
Alternate Name(s):
Prevnar 20, Vaxneuvance, Pneu-C-15, Pneu-C-20
Indications:
- Routine childhood immunization
Administration:
- 0.5 mL IM
- Can be co-administered with the following vaccines (at separate injection sites): Hepatitis B, Pediacel
Dosage:
Pneu-C-15 (Vaxneuvance®):
- 6 weeks to 4 years of age (standard routine vaccination)
- 2, 4 and 12 months of age
Pneu-C-20 (Prevnar20®):
- 6 weeks to 4 years of age who are at increased risk* for (invasive pneumococcal disease) IPD
- 2,4,6 and 12 months of age
Side Effects:
- Local: transient redness at the injection site
- Systemic: fever (more frequently reported when co-administered with other vaccines), drowsiness, irritability
Parameters to Monitor:
- Injection site
- Temperature
Reconstitution and Stability:
Notes:
- Refrigerate until ready to use
- *High-risk conditions include:
Asplenia; certain immune deficiencies; HIV infection; malignant neoplasms; sickle cell disease; chronic renal, hepatic or cardiac disease; chronic neurologic conditions that impede PO secretion clearance; chronic respiratory disease (excluding asthma). Consult latest guidelines from Ottawa Public Health/ Ontario Ministry of Health for complete and updated list.
References:
- Publicly Funded Immunization Schedule for Ontario. Ontario MOH Immunization Schedules 2024
- Chen J, Lau E (editors). Drug Handbook and Formulary. The Hospital for Sick Children.Toronto: Department of Pharmacy; 2017-2018
The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.
CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.
Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.